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The goal of the present study was to in-
vestigate the significance of the Red Cell 
Distribution Width (RDW) in identifying 
the severity, mortality and complications 
of the disease at an early stage in patients 
with acute pancreatitis (AP).
343 patients with AP presented to the 
emergency department during one year 
were included in this retrospective study. 
Demographic, laboratory and imaging re-
sults were recorded. Bedside Index for Se-
verity in AP (BISAP) score was calculated. 
The patients who developed pancreatitis-
related mortality were recorded.
The diagnostic powers of RDW values in 
the diagnosis of BISAP Score (≥3), exitus, 
severe pancreatitis and pancreatitis with 
complication were analysed by means of 
Receiver Operating Characteristic Curve 
(ROC) analysis. p<0,05 was considered 
statistically significant.
The mean age of the subjects was 59,7 
± 18,0 years. Area under curve (AUC) 
in ROC analysis conducted for RDW in 
patients with BISAP score≥ 3 was 0,649 
(95% Cl 0,576-0,722) and p <0,001. For 
developed complications, AUC for RDW 
was 0,558 (95% Cl 0,454-0,662) and p 
was 0,243. For RDW<14,4 cut-off value; 
the sensitivity was 66,25%, specificity was 
71,48% in the prediction of BISAP≥ 3, sen-
sitivity was 87,5%, specificity was 65,14% 
in the prediction of mortality, sensitivity 
was 72,73%, specificity was 71,12% in the 
prediction of severe AP.
RDW is as significant as the BISAP score 
in predicting the severity and mortal-
ity of pancreatitis in the patients with 
acute pancreatitis in the emergency 
department(ED). But it cannot predict the 
complications in AP.
Keywords: Emergency, acute pancreatitis, mor-
tality, severity, complications, redcell distribution 
weight.
INTRODUCTION
Acute pancreatitis(AP) is acute inflamma-
tory disease of the pancreatic gland, which 
usually develops in connection with gall-
stones or alcohol consumption and pro-
gresses with local or systematic symptoms. 
The disease may begin with mild symp-
toms, such as abdominal pain, nausea and 
vomiting and if not treated, it can lead to 
the development of multiple organ dys-
function syndrome, common metabolic 
disorder or sepsis (1-3). The prognosis of 
the disease depends on the severity of the 
disease. 
According to the Atlanta 2012 classifica-
tion, it is divided into three types -  moder-
ate acute pancreatitis (MAP), modarately 
severe acute pancreatitis (MSAP) and se-
vere acute pancreatitis (SAP) (4,5). MSAP 
makes up almost 80% of all pancreati-
tis patients and its mortality is around 
5% (2,6,7). While mortality in MAP and 
MSAP was 1-3%, this rate rises up to 20-
25% in SAP (6,8). It is important to get an 
early risk assessment within the first 24-48 
hours for the patients with AP in the emer-
gency department.
Many studies suggest the use of some scor-
ing systems and laboratuary tests to pre-
dict the severity of acute pancreatitis, in-
cluding; Balthazar Computed tomography 
severity index (9), Bedside Index for Se-
verity in Acute Pancreatitis score (BISAP) 
(7,10,11), C reactive protein (CRP) (12,13), 
blood urea nitrogen(BUN), D- Dimer, pro-
calcitonin levels (11,14). Also, the Ran-
son and Acute Physiology, Age, Chronic 
Health Evaluation II (APACE II) systems 
were used for this purpose (10,15,16). 
However, they are difficult to figure out 
by the bedside since they are clumsy and 
complicated.
The BISAP score is a method of scoring 
calculated based on 5 variables within the 
first 24 hours of admission to the emer-
gency room. These variables are BUN> 
25 mg/dl, state of consciousness, develop-
ment of Systemic Inflammatory Response 
Syndrome(SIRS) symptoms, age being 
older than 60, presence of pleural effusion; 
each parameter is counted as 1 point and 
the score is calculated accordingly (11). 
BISAP has been found as reliable as other 
scores, in the evaluation of patients with 
AP (7,8,10,15).
Red Cell Distribution Weight (RDW) is 
an easy, routine and inexpensive test, as a 
parameter that can be obtained through a 
complete blood count. RDW is the quan-
titative variation in the size of circulating 
red blood cells (RBCs). The rise of RDW 
indicates that the erythrocytes are in the 
circulation, in different volumes and dif-
ferent ways (2,14,17). RDW also increases 
in coronary artery disease, stroke, kidney 
failure and severe infections (18).
Pathophysiological mechanisms between 
mortality and high RDW are not clear 
in AP. Inflammation can help to explain 
them. Inflammation affects the bone mar-
row and iron metabolism (19). Fatality in 
acute pancreatitis occurs either due to sep-
sis which already exists since the beginning 
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or develops following a cytokine storm de-
veloping in the early stage (3, 8, 14). For all 
these reasons, RDW gained popularity in 
predicting the severity and mortality espe-
cially in AP patients (1,2,18,20). The early 
diagnosis of AP patients in the emergency 
department and quick aggressive treatment 
reduces the mortality. Therefore, simple, 
easily accessible and affordable markers are 
needed, which allow investigation on the 
bedside whether the disease will progress 
severely and enable the prediction of the 
progress of the complication and the mor-
tality, without any time restriction. In this 
study, we aimed to investigate the role of 
RDW in predicting the severity of the dis-
ease and mortality in the cases of AP and 
in the prediction of pseudocyst, pancreatic 
necrosis and pancreatic abscess which are 
the complications of pancreatitis.
MATERIALS AND METHODS
Patient selection
This retrospective study was conducted 
between January 1st, 2017 and December 
31st, 2017 at Ataturk Training and Re-
search Hospital. An average of 800 patients 
are admitted to the emergency department 
of our hospital in 24 hours. It is a centre 
that receives referrals from other hospitals 
as it is a 3rd Level hospital which has a 
gastroenterology clinic with ERCP, MRCP 
and EUS facilities. The patients who have 
visited our emergency department and 
have been diagnosed with AP according to 
ICD-10 codes were reviewed. 343 patients 
aged above 18 years old, for whom suffi-
cient data was obtained in their files, were 
included in the study. The patients un-
der 18 years of age, expecting (pregnant) 
women, the patients receiving radiothera-
py-chemotherapy, the patients with severe 
renal failure, those with anaemia (includ-
ing those receiving B12, iron therapy) and 
immunodeficiency patients were excluded 
from the study.
Data collection
Based on the laboratory records obtained 
through the system, White blood cell 
(WBC), blood urea nitrogen (BUN), am-
ylase, lipase, aspartate amino transferase 
(AST), alanine amino transferase (ALT), 
red blood cell distribution weight (RDW) 
values were recorded in the form created. 
Imaging methods used and the results 
achieved were examined. Endoscopic ret-
rograde cholangiography (ERCP), com-
puterized tomography (CT), endoscopic 
ultrasonography (EUS) and magnetic 
resonance cholangiography (MRCP) find-
ings were recorded. (BISAP) scores of the 
patients were calculated using the data 
obtained, and according to 2012 Atlanta 
classification; the patients with BISAP<3, 
no organ failure or local complications 
were classified as moderate acute pancrea-
titis (MAP) (Group 1); the patients with 
BISAP≥3, no permanent organ failure 
but detected with pseudocyst, pancreatic 
necrosis and pancreatic abscess which are 
the complications of pancreatitis, were 
classified as moderately severe acute pan-
creatitis (MSAP) (Group 2); the patients 
with BISAP≥ 3 and at least one persistent 
organ failure were classified as severe acute 
pancreatitis (SAP) (Group 3), and also the 
patients detected with at least one of the 
findings of pancreatic abscess, pseudocyst 
and necrosis were classified as pancreatitis 
with complications (Group 4). The patients 
developing pancreatitis-related mortality 
were recorded.
Statistical method
Statistical analysis of the data was per-
formed using IBM Statistics Version 24 .00 
program. Distribution of continuous data 
was examined with Kolmogorov Smirnov 
test. Mann Whitney U statistical analysis 
was used to compare the continuous data 
between the two groups. The diagnostic 
powers of RDW values in the diagnosis 
of Score (≥3), exitus, severe pancreatitis 
and pancreatitis with complication were 
analysed by means of Receiver Operat-
ing Characteristic Curve (ROC) analysis. 
p<0,05 was considered statistically signifi-
cant.
RESULTS
The average age of 343 patients were in-
cluded in the study is 59,7 ± 18,0 years, 153 
of whom were male (45,6%) and 190 were 
female (53,4%). Looking at the severity of 
the disease; 19.2% of patients were found 
to be SAP, 69.68% were MAP and MSAP, 
4.7% were exitus. The rate of patients de-
veloping at least one of the complications 
was found 11.1%. The score value of 23,3% 
patients was found 3 and above, consid-
ering the distribution according to the 
BISAP Score.
The most common etiological cause was 
found to be the gallstones by 52,5 %. Oth-
ers included 39,4% idiopathic, 5,2% cancer, 
2.0% post ERCP, 1.2% alcohol. Looking at 
the proportion of the imaging methods 
used; 87,8% EUS, 36,2% CT, 28,9% ERCP 
and 6,7% MRCP were performed.
Examining the relationship of the labora-
tory results obtained, with BISAP score, 
survival/recovery, severe pancreatitis and 
complication; ALT, AST, BUN, CRP and 
RDW values of the patients with a BISAP 
score of ≥ 3 were found significantly higher 
Table 1. Relationship of laboratory values with BISAP score.
  BISAP SCORE p
<3 >3 
Median (IQR) Median (IQR)
Alanine Aminotransferase 87,5 (196,25) 322 (367) 0,000
Amylase 706 (1356) 1011,5 (1503,5) 0,055
Aspartate Aminotransferase 94 (163,75) 320 (401) 0,000
Blood Urea Nitrogen 14 (8) 21 (15,75) 0,000
C-Reaktive Protein 1,21 (4,665) 2,51 (7,6975) 0,015
Lipase 1794 (3914,5) 2316,5 (4687,5) 0,103
Redcell Distributionon Weight 13,8 (1,5) 14,95 (2,175) 0,000
White Blood Cell 10,98 (5,7) 12,23 (8,175) 0,005
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than the values of cases whose scores were 
less than “3” (p<0,05) (table 1). The BUN 
and RDW values of the exitus cases were 
found significantly higher than the surviv-
ing cases (p <0,05) (table 2). ALT, amylase, 
AST, BUN, lipase, RDW, WBC, and values 
of the cases detected with severe pancreati-
tis were found significantly higher than the 
cases with no severe pancreatitis (p<0.05) 
(table 3). The parameters above were not 
statistically significant in MAP and MSAP. 
Laboratory values in the patients classified 
as having complications were not found 
statistically significant as compared to the 
other groups (table 4). In terms of other 
variables, no statistically significant differ-
ence was found between the groups (p>0, 
05). The result of ROC analysis conducted 
for the power of RDW in predicting the 
mortality showed: RDW AUC 0,754 (95% 
Cl 0,670-0,838), p<0.001(Graphic1). For 
RDW>14.4 cut-off value of RDW values; 
sensitivity in predicting mortality was 
87.5% and specificity 65.14%.
DISCUSSION
Acute pancreatitis is an inflammatory dis-
ease of the pancreas, which can lead even 
to death if left untreated. The factors caus-
ing inflammation are mostly the gallstones 
and use of alcohol. Looking at the previ-
ous studies, the rate of developing acute 
pancreatitis due to gallstone was found 
between 40-63% (2,3,6,16). In our study, 
we found the rate of developing acute pan-
creatitis due to gallstone as 52,5%, in com-
Table 2. The relationship of laboratory values with mortality
 MORTALITY p
live Ex
Median (IQR) Median (IQR)
Alanine Aminotransferase 111 (263) 36,5 (268,5) 0,140
Amylase 807 (1374,75) 609,5 (1374,75) 0,643
Aspartate Aminotransferase 117 (211,5) 88 (317) 0,599
Blood Urea Nitrogen 15 (9) 23,5 (13,5) 0,001
C-Reaktive Protein 1,41 (5,0825) 2,57 (10,2175) 0,127
Lipase 2072 (3992) 1397 (2120,75) 0,376
Redcell Distributionon Weight 13,9 (1,725) 15,25 (1,25) 0,001
White Blood Cell 11,2 (5,6775) 10,63 (8,4175) 0,506
Table 3. The relationship of laboratory values with severity of disease.
 SEVERE PANCREATITIS p
NO YES
Median (IQR) Median (IQR)
Alanine Aminotransferase 88 (193,75) 374 (364) 0,000
Amylase 698 (1379,25) 1114 (1748,5) 0,006
Aspartate Aminotransferase 97 (161,75) 381,5 (427,5) 0,000
Blood Urea Nitrogen 15 (8,75) 19,5 (15) 0,000
C-Reaktive Protein 1,4 (5,4475) 1,99 (4,8225) 0,387
Lipase 1791 (3668) 2502,5 (4762,5) 0,013
Redcell Distributionon Weight 13,8 (1,5) 15,05 (2,05) 0,000
White Blood Cell 11,04 (5,845) 11,86 (7,1775) 0,047
Table 4. The relationship of laboratory values with complications.
 COMPLICATION p
NO YES
Median (IQR) Median (IQR)
Alanine Aminotransferase 116 (266) 62 (106,5) 0,012
Amylase 788 (1380,5) 802 (1161) 0,230
Aspartate Aminotransferase 121,5 (217) 69 (208) 0,152
Blood Urea Nitrogen 16 (10,5) 15,5 (8,5) 0,266
C-Reaktive Protein 1,43 (4,815) 2,74 (14,96) 0,063
Lipase 2155 (3912,5) 964 (4216) 0,100
Redcell Distributionon Weight 14 (1,8) 14,05 (2,75) 0,243
White Blood Cell 11,06 (6,2) 11,64 (5,265) 0,134
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pliance with the literature. When examined 
according to the gender of the patients, 
55,84% of the patients in our study were 
female, with an average age of 59,7.
Mortality in acute pancreatitis is associ-
ated with multiple organ failure and sep-
tic complications. The development and 
progression of multiple organ failure is 
related to the inflammatory process. The 
severity of inflammation affects the course 
and mortality of the disease. Based on this 
fact, two periods were defined, at which the 
mortality peaks in the course of AP. The 
first is the early period which may lead to 
multiple organ failure and SIRS that devel-
ops in the first week and the second is the 
late period during which persistent organ 
dysfunction is observed, accompanied by 
infection and sepsis that develop between 
1-3 weeks (17,21). Early detection of the se-
verity of the disease and initiation of proper 
treatment reduces the late period complica-
tions and mortality. A number of Scoring 
systems have been developed to predict the 
severity and mortality in AP. BISAP score, 
which is one of them, was developed for the 
first time by Wu et al, in an attempt to pre-
dict the severity of disease in patients with 
AP. In this study, the reliability of the score 
was compared to APACHE II score value 
calculated in patients with AP (11). 12 ar-
ticles were examined in the review study 
conducted by Subash et al. and it was found 
that BISAP displayed a good performance 
in the prediction of SAP and BISAP score 
was 3 and above particularly in patients 
with a severe pancreatitis and persistent or-
gan failure lasting longer than 48 hours (7). 
Ting Z et al., found out in their study that 
BISAP≥3 value for the patients with RAN-
SON score≥3, APACHE II score≥8 had a 
correlation with the severity of AP (2). In 
our study, the diagnosis of SAP was statisti-
cally significant in patients with BISAP≥3.
RDW is a parameter that shows the dis-
tribution width of the circulating eryth-
rocytes. Its level increases during inflam-
matory periods. In the RDW studies 
conducted by Kilic M. O. et al., and Ucar 
Karabulut K. et al., it was discovered that 
RDW has predicted the severity of AP 
(16,20). In the study performed by Thing 
Z. et al., on the patients diagnosed with AP, 
RDW has a correlation with BISAP in pre-
dicting the severity of AP (2). In our study, 
RDW 14,92±1,67 value for patients with 
BISAP Score≥3 was found to be statistically 
significant (p<0,0005).
Studies with RDW have shown that it is 
related not only to the severity but also 
to the mortality of the disease. Especially, 
it was revealed that RDW is related with 
the mortality in patients with cardiac dis-
eases, malignancies, infections, renal dis-
eases, pulmonary diseases and the patients 
with cerebro vasculer disease in particular 
(17,22). In the study conducted by Jo et al., 
where they investigated the relationship of 
RDW with mortality in patients with severe 
sepsis and septic shock, RDW level was 
found out to be considerably high in the 
exitus (22). RDW is nowadays used to pre-
dict the mortality in AP which is an inflam-
matory disease. This is because mortality in 
AP is associated with multiple organ failure 
and septic complications. Ina study by Pay-
man M. et al., elevated RDW was found to 
be associated with mortality in patients di-
agnosed with AP and that 14.55 as the cut-
off value of RDW had 80% sensitivity, 85% 
specificity (1). In a study by Wenzheng Z. et 
al., RDW was compared with albumin and 
creatinine in determining the mortality in 
AP. The values of RDW at and above 14.45 
was found to predict the mortality with a 
sensitivity of 88,9% (3). In the review study 
of Hemant G. et al., 7 retrospective studies 
were examined and it was noted that RDW-
was significantly higher in the deceased pa-
tients than in the survivors. Furthermore, 
in 4 of these studies, RDW was found to be 
an independent risk factor as an indicator 
of mortality (14). In a study performed by 
Senol et al, 14,8 value of RDW was found 
significant in predicting the mortality in 
patients with AP. And also, when compared 
toWBC, platelet, BUN, calcium and albu-
min, RDW was found as an independent 
prognostic factor which predicts the mor-
tality (17). In the study by Yao et al., they 
compared the RDW values of the patients 
with acute pancreatitis to those of the nor-
mal population. They divided the pancrea-
titis patients into two groups as SAP and 
MAP and RDW wasfound significantly 
high in SAP patients and the exitus (18). 
In our study, RDW>14,4 cut-off value had 
87,5% sensitivity, 65,14% specificity in pre-
dicting the mortality. According to these 
results, our study supported the fact that 
RDW is related with the severity and mor-
tality of the disease.
When the literature is reviewed, there is 
no study investigating whether RDW also 
predicts the complication, as well. Develop-
ment of complication affects the mortality 
and rate of morbidity in acute pancreatitis. 
In the study conducted by Biberoglu et al., 
it was found out that two prognostic fac-
tors have been used in calculation of CT 
severity index and whether one of them 
Graphic 1. ROC analyse of comparasion 
BISAP score with RDW
Graphic 2. ROC analyse of RDW with mor-
tality.
Graphic 3. ROC analyse of RDW with se-
verity of disease.
Graphic 4. ROC analyse of  RDW with 
complications.
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is necrosis and the amount of necrosis is a 
factor affecting the mortality directly (9). 
Therefore, in our study, we classified the 
patients detected with abscess, necrosis and 
pseudocyst as a separate group and looked 
into the relationship with RDW. In our 
study, no statistical relationship was found 
between the RDW value measured in the 
blood sample taken from the patient at 
emergency department and development 
of complication. No significant result was 
obtained in the ROC analysis performed 
with RDW value measured for patients 
who have developed complications.
Although we cannot fully explain why 
RDW cannot predict the complication in 
cases with complications, this may be due 
to the fact that complications develop later 
in the disease process, e.g. 1 and 3 weeks 
later, and the patient does not produce any 
systemic warning as he/she is under treat-
ment and therefore does not affect the he-
matopoietic system. Our study is the first 
to investigate the relationship between the 
cases developing complications in pancrea-
titis and RDW in the literature. However, 
it needs further and comprehensive studies 
on this subject.
In conclusion, RDW value in patients 
with acute pancreatitis is as valuable as the 
BISAP score in predicting the severity and 
mortality of pancreatitis in the emergency 
department. It is advantageous as opposed 
to BISAP, in that it can be treated on the 
bedside and no additional parameters 
are needed. Moreover, it can be obtained 
through affordable and routine blood 
count. But it cannot predict the complica-
tions in AP.
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